Increased Risk of Chronic Fatigue and Hair Loss Following COVID-19 in Individuals with Hypohidrotic Ectodermal Dysplasia

September 2021 in “ Orphanet Journal of Rare Diseases ”

Verena Hennig, Wolfgang Schuh, Antje Neubert, Dirk Mielenz, Hans‐Martin Jäck, Holm Schneider

hair loss hypohidrotic ectodermal dysplasia ectodysplasin A signalling SARS-CoV-2 COVID-19 chronic fatigue HED

TLDR People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

The document presents three studies on the increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia (HED), a rare genetic disorder. The first study involved 120 HED patients, with 60% reporting chronic fatigue and 40% reporting hair loss post-recovery. The second study involved 15 HED patients and 149 control subjects, finding that 83% of HED patients with completely abrogated ectodysplasin A signalling experienced chronic fatigue, compared to 25% of HED patients with residual activity of this pathway and 21% of control subjects. Hair loss was more common in HED patients (64%) than in the control group (13%). The third study involved 5 HED patients, with 83% reporting severe fatigue and 57% reporting hair loss post-COVID-19. The studies concluded that HED patients are at an increased risk of long-term consequences of a SARS-CoV-2 infection, such as chronic fatigue and hair loss, and recommended preventive vaccination against COVID-19 for these individuals.

View this study on ojrd.biomedcentral.com →

Discuss this study in the Community →

Cited in this study

5 / 5 results

research COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings

213 citations , May 2021 in “Annals of internal medicine”

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

research Telogen Effluvium: A Review of the Science and Current Obstacles

23 citations , March 2021 in “Journal of Dermatological Science”

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , December 2020 in “Journal of the European Academy of Dermatology and Venereology”

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

research Mutational Spectrum in 101 Patients with Hypohidrotic Ectodermal Dysplasia and Breakpoint Mapping in Independent Cases of Rare Genomic Rearrangements

30 citations , June 2016 in “Journal of Human Genetics”

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

research Genotype-Phenotype Correlation in Boys with X-Linked Hypohidrotic Ectodermal Dysplasia

35 citations , April 2014 in “American Journal of Medical Genetics”

Boys with less severe EDA mutations in XLHED have milder symptoms and better sweat and hair production.

1 / 1 results

research Increased Risk of Chronic Fatigue and Hair Loss Following COVID-19 in Individuals with Hypohidrotic Ectodermal Dysplasia

2 citations , September 2021 in “Orphanet Journal of Rare Diseases”

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.